Could Massachusetts un-legalise cannabis? Question 8, explained

For a decade, American election nights were reliably good news for cannabis legalisation. Between 2012 and 2023, voters approved 17 adult-use measures in 16 states and Washington DC. (One, South Dakota's, was later overturned by the courts.)

As of 13 October 2026, not one adult-use legalisation measure is on any state's ballot. The cannabis questions that did make it point the other way. In Massachusetts, voters are asked whether to shut down the legal retail market they created in 2016. In Idaho, they are asked whether to stop themselves from ever legalising anything by petition.

Both are on the 3 November ballot. Neither is as simple as its headline, so we read the actual text.

Question 8: what a Yes vote does#

Massachusetts voters legalised adult-use cannabis in 2016 with Question 4, which passed with more than 53% of the vote. The first two shops, Cultivate in Leicester and New England Treatment Access in Northampton, opened on 20 November 2018.

Question 8 is one of nine questions on the Massachusetts ballot. The Secretary of the Commonwealth's Information for Voters guide titles it "Prohibit Retail Sale of Adult Recreational Use Marijuana". The petition behind it is called "An Act to Restore a Sensible Marijuana Policy", a title that settles the argument before you reach the first clause. (The No campaign's names are no shrinking violets either. Everyone in a ballot fight is a branding agency.) The guide says a Yes vote "would prohibit the legalization, regulation, and taxation of the retail sale of adult recreational use marijuana" and change the penalties for possession. A No vote "would make no change to the law relative to marijuana."

Reading the petition text, a Yes vote would:

• Repeal chapters 94G and 64N of the General Laws, the adult-use regulation and tax laws, from 1 January 2028. Nothing changes before then.
• Keep medical cannabis and the Cannabis Control Commission, which would regulate only the medical market. Licensed adult-use businesses could apply on an expedited basis for medical licences and sell their remaining stock to medical treatment centres.
• Lower the possession limit. Adults 21 and over could hold up to one ounce, no more than five grams of it concentrate. One to two ounces would become a civil offence: a US$100 penalty and forfeiture. Under-21s caught with two ounces or less would face a civil penalty plus a drug awareness programme. A law signed in April 2026 doubled the limit for carrying and gifting to two ounces, so a Yes vote would wind that back.
• End the cannabis social equity programme and mandatory host-community agreements, according to the state's highest court, which cleared the question in June.

On money, the Secretary's fiscal statement says repeal "would reduce the amount that state and municipal governments receive". In fiscal year 2025, retail cannabis taxation raised about US$280 million for the state and US$50 million for local governments.

The home-grow wrinkle

Here the reporting splits. WBUR says home cultivation would stay legal. Boston.com, Cannabis Business Times and Ohio State's tracker say it would end.

We side with the text. Adults' right to grow up to six plants sits in section 7 of chapter 94G, which the petition repeals in full, and the text offers nothing in its place. The only mention of growing at home is an instruction for the Commission to issue advisory guidelines on cultivation "within a person's primary residence" under the medical programme. The official summary does not mention home growing either way. A UNH poll described the question to respondents as repealing sales "and the personal cultivation of cannabis in homes". We flag it because it is the one place where mainstream coverage disagrees; the full text is in the state guide.

Question 8 would also be a first. Researchers at Ohio State and the Rockefeller Institute both describe it as an attempt that no state has made: voters dismantling a regulated adult-use market after shops have opened.

The money and the arguments#

The Yes campaign is the Coalition for a Healthy Massachusetts. Almost all of its money comes from Smart Approaches to Marijuana Action, the political arm of the national anti-legalisation group led by Kevin Sabet, a former drug policy adviser under Presidents George W. Bush and Barack Obama. By the committee's latest filing with the state's Office of Campaign and Political Finance, as reported on 12 October, it had raised about US$3.53 million since September 2025, US$3.48 million of it from SAM Action in five cheques, the latest US$305,000 on 29 September; the totals move as filings do. Sabet says Question 8 "is simply about the commercialization of marijuana" and does not touch a person's right to use. His side's argument in the state guide, signed by a retired physician, points to modern high-potency products, psychosis and anxiety, and fatal car crashes involving cannabis.

The No campaign is led by the Committee to Protect Cannabis Regulation, which had raised about US$2.34 million by the same filing, mostly from cannabis retailers and manufacturers. Named donors include INSA (US$265,000), Ascend Wellness Holdings (US$250,000), Vireo Health (US$125,000) and the Retailers Association of Massachusetts (US$100,000). In other words, the money on both sides is interested money. The No argument in the guide, from the Massachusetts Cannabis Coalition's Ryan Dominguez, says repeal would return the market to illicit sellers, close small businesses and cost jobs and tax revenue. He cites CDC data showing Massachusetts high school cannabis use fell from 26% in 2019 to 12% in 2025.

WBUR reports that the Yes campaign points to a Mass General Brigham study, so here it is with its size. The analysis in the American Journal of Preventive Medicine looked at 7,350 psychiatric emergency visits at one hospital between 2017 and 2019. Among patients aged 12 to 17, THC-positive urine tests rose from 5% to 17.3% and cannabis-related disorder diagnoses from 3.2% to 12.1%. Other age groups showed no comparable rise in diagnoses. The authors caution that it is a single site, and that the retail market has grown more than tenfold since.

Dr Scott Hadland, an adolescent medicine specialist at Mass General Brigham for Children who takes no position on Question 8, told WBUR he worries about high-potency products and teen psychosis. He also doubts repeal would help much, since those products would stay widely available. On 4 October Governor Maura Healey said on WCVB that she would vote no, and on 6 October US Representative Ayanna Pressley joined the No campaign. The legislature's initiative committee, for its part, recommended on 4 May that lawmakers "take no action", citing implementation problems and revenue loss.

The polls#

We found two public polls of likely voters from September, and none newer as of 13 October; they agree on direction rather than size.

The UNH poll was run by the university's own Survey Center under its States of Opinion Project; its release does not say who funded it. The MassINC poll was sponsored by CommonWealth Beacon, a news outlet, and conducted online by the MassINC Polling Group; its margin of error includes the design effect. Neither release names a campaign as sponsor. The two polls asked different questions. UNH asked about repealing sales "and the personal cultivation of cannabis in homes". MassINC read respondents the official ballot summary (a Yes vote "would prohibit the legalization, regulation, and taxation of the retail sale of adult recreational use marijuana"). Wording matters on a repeal question where "Yes" means "stop". A poll is not a result, and Massachusetts voters also have eight other questions to get through.

Idaho HJR 4: who decides#

Idaho's measure is a different animal. House Joint Resolution 4 would amend Article III, section 26 of the Idaho Constitution, the part about intoxicating liquor, so that "only the legislature of the state of Idaho shall have power and authority to legalize" marijuana, narcotics or other psychoactive substances. In practice that closes the citizen-initiative route for all three, including for psychedelics. It does not make anything illegal. It decides who may change the law.

The House passed it on 5 March 2025 by 58 to 10, all 58 yeses Republican, the noes nine Democrats and one Republican. The Senate passed it 29 to 6 on 11 March, strictly along party lines. Amendments need two-thirds in each chamber; voters need only a simple majority. Senator Scott Grow, a Republican cosponsor, said: "We are acting because that's our responsibility." Democratic Senator James Ruchti, who voted no, said: "We should respect the people." In June 2026 the Legislative Council approved ballot wording that Republicans had revised, over Democratic objections, to drop a line saying the amendment gives the Legislature "total power over drug legalization".

The timing is the interesting bit. A medical cannabis initiative, run by the Natural Medicine Alliance of Idaho, did not make the 2026 ballot. The Secretary of State announced on 14 July that it fell short: it needed 70,725 valid signatures, and at most 58,024 were certified. It also had to hit 6% of voters in 18 of 35 legislative districts and reached 13. Residency could not be verified for 293 circulators, and Secretary Phil McGrane referred possible fraud to state police, adding that "a referral is not a finding of criminal liability." A second effort to decriminalise cannabis filed no signatures at all, per Ohio State's tracker. Idaho Capital Sun reports organisers have tried and failed to qualify medical or decriminalisation measures for a decade.

The ones that didn't make it#

The honest summary is that almost everything cannabis-related failed to reach a 2026 ballot, in both directions. Per Ohio State's drug ballot tracker, which we have checked against local reporting:

• Florida: an adult-use initiative missed the 1 February signature deadline. Officials invalidated nearly 71,000 signatures; the campaign contested that, and the Florida Supreme Court declined a rehearing on 9 March. The 2024 version won 55.9% but needed 60%.
• Nebraska: a recreational initiative fell short on signatures, per the tracker.
• Arizona: a measure to ban commercial sales, sponsored by consultant Sean Noble and reportedly funded by Smart Approaches to Marijuana, was dropped in May.
• Maine: a repeal effort did not file in time. It could return in 2027, with signatures due by 8 June 2027.
• Ohio: a referendum on Senate Bill 56 collected too few signatures and was suspended on 18 March. The law took effect on 20 March, capping flower at 35% THC and extracts at 70%, capping adult-use retailers at 400 and confining intoxicating hemp products to licensed cannabis shops.

So "momentum has shifted" is too neat. Pro-legalisation drives lost to signature rules and legal fights; repeal drives lost to the same. The one that cleared every hurdle is Question 8. The Rockefeller Institute's Heather Trela, writing in April, expected "contested consolidation" rather than rapid expansion, and noted that Florida's new petition rules and Idaho's HJR 4 make citizen initiatives harder.

Federal law is in a similar half-state. Medical marijuana was moved to Schedule III in April while the rest of the rescheduling process is paused, and, as we explain in "Last orders: America's petrol-station THC has until 11 December", tighter hemp THC limits take effect on 11 December.

What happens next#

Polls close on 3 November. If Question 8 passes, nothing changes on the shop shelves until 1 January 2028, which leaves Beacon Hill more than a year to amend, delay or argue about it. If it fails, the status quo stands. If Idaho's HJR 4 passes, the legislature alone decides; if it fails, petitions remain possible, just not this cycle.

We will update this piece after the results. Until then, the best advice we can give any voter is the dullest: read the text, not the title.

Fact-checked 13 October 2026. Editor verdict: Pass With Edits.